Chief Strategy and Innovation Officer, Blue Cross and Blue Shield of North Carolina
Managing Director, D.E. Shaw and Co., L.P.
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
|Bio Roundup: Drug Pricing, Cystic Fibrosis Showdown, Myovant & More||Ben Fidler||10/28/16||National|
|After New Data, FDA Bucks Advisory Panel, Approves Sarepta’s Duchenne Drug||Ben Fidler||09/19/16||Boston|
|Near-Term FDA Nod Unlikely For Duchenne Drug After Negative Vote||Ben Fidler||04/25/16||Boston|
|Page 1 of 1|